Verve Therapeutics (VERV) announced the clearance of its Investigational New Drug application by the U.S. Food and Drug Administration for ...

Reporting to MedWatch is easy, confidential, and secure. You provide information about your experience on a MedWatch form. The FDA encourages you to have your health care professional either ...

EVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...

Nearly 99% of new chemicals used in food or food packaging since 2000 were green-lit for use not by the FDA but by the food ... the cost to consumers in the form of higher prices, Califf said.

The FDA’s Vaccines and Related Biological Products Advisory Committee had been scheduled to meet Thursday to weigh in on the composition of the flu shots, but that session was canceled without ...

It's an important meeting. What's the plan for flu vaccines this year," Dr. Paul Offit, a member of the FDA advisory committee and director of the Vaccine Education Center at Children's Hospital ...

(Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the fourth ...

This would increase transparency for consumers as well as the FDA's oversight of food ingredients considered to be safe, Kennedy said. Sign up here. "For far too long, ingredient manufacturers and ...

The collaboration aims to enhance commercial assays and prepare the test for potential FDA application ... including its annual report on Form 20-F filed on April 9, 2024. The Company’s SEC ...